1. Metabolic Enzyme/Protease Cell Cycle/DNA Damage Immunology/Inflammation NF-κB Apoptosis Autophagy
  2. Mitochondrial Metabolism DNA/RNA Synthesis Reactive Oxygen Species (ROS) Apoptosis Autophagy Caspase Bcl-2 Family Atg8/LC3
  3. XAN-5

XAN-5 是一种线粒体 DNA G-四链体 (mtG4) 配体,其 Kd 值为 3.8 μM。XAN-5 可选择性结合并稳定 mtG4 结构,从而破坏线粒体基因转录与 DNA 复制。XAN-5 可诱导线粒体功能障碍、活性氧 (ROS) 过量产生、G0 期阻滞及半胱天冬酶依赖性细胞凋亡 (apoptosis)。XAN-5 可抑制自噬 (autophagy) 并诱导免疫原性细胞死亡。XAN-5 可抑制小鼠肝癌模型中的肿瘤生长,同时增强肿瘤浸润性 CD4+ 和 CD8+ T 细胞。XAN-5 可同时靶向两种肿瘤耐药机制。XAN-5 可用于肝癌的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

XAN-5

XAN-5 Chemical Structure

CAS No. : 3062796-70-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

XAN-5 is a mitochondrial DNA G-quadruplex (mtG4) ligand with a Kd of 3.8 μM. XAN-5 selectively binds and stabilizes mtG4 structures, disrupting mitochondrial gene transcription and DNA replication. XAN-5 triggers mitochondrial dysfunction, ROS overproduction, G0 phase arrest and caspase-dependent apoptosis. XAN-5 inhibits autophagy and induces immunogenic cell death. XAN-5 inhibits tumor growth in a mouse liver cancer model while enhancing tumor-infiltrating CD4+ and CD8+ T cells. XAN-5 targets two cancer resistance mechanisms simultaneously. XAN-5 can be used for the research of liver cancer[1].

IC50 & Target[1]

Caspase-8

 

Caspase-9

 

Caspase-3

 

Bax

 

Bcl-2

 

bad

 

体外研究
(In Vitro)

XAN-5 (10 μM; 2 h) 可稳定 mtG4 模型 mt6363,其 ΔTm 为 10 °C[1]
XAN-5 (5 μM; 30 min) 可选择性地在 HepG2 细胞的线粒体中富集[1]
XAN-5 (0.25-4 μM; 24 h) 可强效抑制肝癌 HepG2 细胞的增殖 (IC50 = 1.8 μM),同时对正常肝脏及乳腺上皮细胞的毒性较低[1]
XAN-5 (1-4 μM; 24 h) 可显著降低 HepG2 细胞中 OXPHOS 基因 ATP6、CYTB 和 COX-1 的转录水平[1]
XAN-5 (1-4 μM; 24 h) 可在体外以剂量依赖方式抑制 HepG2 细胞中的 mtDNA 复制,在 4 μM 浓度下可使 D-Loop 拷贝数降低 80%[1]
XAN-5 (1-4 μM; 24 h) 可在 HepG2 细胞中诱导浓度依赖性的活性氧过量生成,线粒体膜电位耗散并降低 ATP 水平[1]
XAN-5 (1-4 μM; 24 h) 于 1 μM 浓度时可诱导 HepG2 细胞发生 G0/G1 期阻滞,而 2 μM 和 4 μM 浓度则可使亚 G0 期凋亡细胞群分别逐步增加[1]
XAN-5 (1-4 μM; 24 h) 可在 HepG2 细胞中诱导剂量依赖性细胞凋亡,4 μM 浓度下膜联蛋白 V 阳性细胞占比为 30%[1]
XAN-5 (1-4 μM; 24 h) 可在体外以剂量依赖方式抑制 HepG2 细胞的自噬,其证据包括 LC3B-II 转化减少、p62 蓄积、ATG 基因表达受抑以及 DAPGreen 荧光强度降低,该效应由活性氧介导[1]
XAN-5 (1-4 μM; 24 h) 可诱导 HepG2 细胞发生免疫原性细胞死亡,其特征为钙网蛋白表达上调、细胞表面钙网蛋白水平升高以及细胞外 ATP 水平上升[1]
XAN-5 (0.25-4 μM; 0-7 days) 以浓度依赖性方式显著抑制 HepG2 细胞的迁移、集落形成以及 3D 肿瘤球体的生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Real Time qPCR[1]

Cell Line: HepG2 cells
Concentration: 1, 2, 4 μM
Incubation Time: 24 h
Result: Reduced ATP synthase subunit 6 (ATP6), Cytochrome b (CYTB), and cytochrome c oxidase subunit 1 (COX-1) expression.

Cell Cycle Analysis[1]

Cell Line: HepG2 cells
Concentration: 1, 2, 4 μM
Incubation Time: 24 h
Result: Induced G0/G1 phase arrest at 1 μM, increasing the proportion of cells in this phase from 57.9% to 60.9% while decreasing the G2/M phase population from 17.1% to 14.2%.
At 2 and 4 μM, progressively increased the sub-G0 phase (indicative of apoptotic cell death) from 8.9% to 12.2% and finally 30%, respectively.

Western Blot Analysis[1]

Cell Line: HepG2 cells
Concentration: 1, 2, 4 μM
Incubation Time: 24 h
Result: Led to cytochrome c release from mitochondria, cleavage of caspase-9, caspase-3, and PARP, activation of caspase-8, and cleavage of BID into truncated BID (tBID), confirming activation of both intrinsic (mitochondrial) and extrinsic (death receptor) apoptotic pathways.
Reduced Bcl-2 and Bad levels and increased Bax levels.

Cell Autophagy Assay[1]

Cell Line: HepG2 cells
Concentration: 1, 2, 4 μM
Incubation Time: 24 h
Result: Effectively downregulated the LC3B-II/LC3B-I ratio, caused accumulation of p62/SQSTM1, decreased expression of autophagy-related genes (ATG3, ATG5, ATG7, and ATG12), and reduced DAPGreen fluorescence intensity in a dose-dependent manner, indicating impaired autophagosome formation and autophagic flux inhibition.
Reversed by the ROS scavenger N-acetylcysteine, confirming ROS mediation.
体内研究
(In Vivo)

XAN-5 (10 mg/kg;每 48 小时一次,持续 6 天) 在 BALB/c 小鼠 H22 肝癌模型中可诱导肿瘤体积缩小 59%,抑制肿瘤细胞增殖,提高肿瘤浸润及脾脏中 CD4+ 和 CD8+ T 细胞的频率,且在测试剂量下未观察到明显的全身毒性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

570.05

Formula

C29H28ClNO7S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
XAN-5
目录号:
HY-181599
需求量: